RNA icon

Avidity Biosciences

219 hedge funds and large institutions have $3.96B invested in Avidity Biosciences in 2025 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 95 increasing their positions, 65 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
219
Holders Change
-16
Holders Change %
-6.81%
% of All Funds
2.98%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.12%
New
32
Increased
95
Reduced
65
Closed
45
Calls
$9.04M
Puts
$30.3M
Net Calls
-$21.3M
Net Calls Change
-$19.9M
Name Holding Trade Value Shares
Change
Shares
Change %
LCM
251
Legato Capital Management
California
-$301K -10,337 Closed
TC
252
Torno Capital
Massachusetts
-$262K -9,000 Closed
XT
253
XTX Topco
Cayman Islands
-$258K -8,889 Closed
Janney Montgomery Scott
254
Janney Montgomery Scott
Pennsylvania
-$253K -8,700 Closed
PEAK6
255
PEAK6
Illinois
-$218K -7,500 Closed
GCP
256
GSA Capital Partners
United Kingdom
-$213K -7,320 Closed
VF
257
Virtu Financial
New York
-$210K -7,219 Closed
QCM
258
Quantinno Capital Management
New York
-$204K -7,026 Closed
CIAM
259
Caitong International Asset Management
Hong Kong
-$115K -3,939 Closed
VEA
260
Virtus ETF Advisers
New York
-$61.2K -2,106 Closed
HT
261
Headlands Technologies
Illinois
-$60K -2,062 Closed
Federated Hermes
262
Federated Hermes
Pennsylvania
-$45.9K -1,577 Closed
RS
263
R Squared
Hong Kong
-$14.2K -490 Closed
MAM
264
Meeder Asset Management
Ohio
-$1.6K -55 Closed